New transplant method for childhood leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new combination of medicines to help donor cord blood cells grow better in children with leukemia after a transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child diagnosed with acute leukemia.
- You must be scheduled for a stem cell transplant using cord blood.
- You should not have severe organ failure affecting multiple body systems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This trial tests different ways to manage stem cell transplants in children and young adults with acute lymphoblastic leukemia (ALL). It aims to find the best approach to improve outcomes and reduce complications.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This Phase 2 trial studies using a cord blood transplant after finding it is risky enough that standard treatment may not be sufficient. It may help certain children and young adults with specific leukemia, lymphoma, and some non-cancer blood/immune or inherited disorders who do not have a well-matched donor available in time.
This trial tests a new way to do cord blood transplants for people with high-risk leukemia. It adds extra white blood cells (granulocytes) to boost the immune system and help fight the disease, with the goal of improving outcomes.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.